Literature DB >> 20971314

In search of blood tests for thoracic aortic diseases.

Santi Trimarchi1, Giuseppe Sangiorgi, Xiangpeng Sang, Vincenzo Rampoldi, Toru Suzuki, Kim A Eagle, John A Elefteriades.   

Abstract

A number of new diagnostic screening tools have been developed for the assessment of acute and chronic diseases of the thoracic aorta. Although standardized blood-based tests capable of detecting individuals at risk for aortic aneurysm and dissection disease are not yet available, our current knowledge is expanding at a rapid rate and the future is very promising. In this review, an update of the contemporary knowledge on blood tests for detecting thoracic aortic diseases in both preclinical and clinical settings is provided, offering the potential to predict adverse aortic events, such as enlargement, rupture, and dissection.
Copyright © 2010 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20971314     DOI: 10.1016/j.athoracsur.2010.04.111

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  11 in total

1.  New Insights Into Aortic Diseases: A Report From the Third International Meeting on Aortic Diseases (IMAD3).

Authors:  Helena Kuivaniemi; Natzi Sakalihasan; Frank A Lederle; Gregory T Jones; Jean-Olivier Defraigne; Nicos Labropoulos; Victor Legrand; Jean-Baptiste Michel; Christoph Nienaber; Marc A Radermecker; John A Elefteriades
Journal:  Aorta (Stamford)       Date:  2013-06-01

Review 2.  Thoracic aortic aneurysm: unlocking the "silent killer" secrets.

Authors:  Ayman A Saeyeldin; Camilo A Velasquez; Syed Usman B Mahmood; Adam J Brownstein; Mohammad A Zafar; Bulat A Ziganshin; John A Elefteriades
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-12-04

3.  Aortic gene dictionary in the precision medicine era-update from the Aortic Institute at Yale New Haven.

Authors:  Dimitra Papanikolaou; Mohammad A Zafar; Bulat A Ziganshin; John A Elefteriades
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2022-02-24

Review 4.  Type B Aortic Dissection: A Review of Prognostic Factors and Meta-analysis of Treatment Options.

Authors:  Thomas Luebke; Jan Brunkwall
Journal:  Aorta (Stamford)       Date:  2014-12-01

Review 5.  Guilt by association: a paradigm for detection of silent aortic disease.

Authors:  Bulat A Ziganshin; John A Elefteriades
Journal:  Ann Cardiothorac Surg       Date:  2016-05

6.  Quantitative proteomics analysis by isobaric tags for relative and absolute quantitation identified Lumican as a potential marker for acute aortic dissection.

Authors:  Guorong Gu; Weizhong Cheng; Chenling Yao; Jun Yin; Chaoyang Tong; Andrew Rao; Lawrence Yen; Matthew Ku; Jianyu Rao
Journal:  J Biomed Biotechnol       Date:  2011-12-20

Review 7.  Guilt by association: paradigm for detecting a silent killer (thoracic aortic aneurysm).

Authors:  John A Elefteriades; Adam Sang; Gregory Kuzmik; Matthew Hornick
Journal:  Open Heart       Date:  2015-04-24

8.  Genetic variants in FBN-1 and risk for thoracic aortic aneurysm and dissection.

Authors:  Olga A Iakoubova; Carmen H Tong; Charles M Rowland; May M Luke; Veronica E Garcia; Joseph J Catanese; Remo M Moomiaie; Peter Sotonyi; Gyorgy Ascady; Demitrios Nikas; Panagiotis Dedelias; Maryann Tranquilli; John A Elefteriades
Journal:  PLoS One       Date:  2014-04-17       Impact factor: 3.240

9.  A fatal outcome of thoracic aortic aneurysm in a male patient with bicuspid aortic valve.

Authors:  Blanka Milanowska; Ewa Michalak; Ilona Michałowska; Eugeniusz Szpakowski; Anna Konopka; Anna Klisiewicz; Zofia Teresa Bilińska
Journal:  Postepy Kardiol Interwencyjnej       Date:  2013-09-16       Impact factor: 1.426

10.  Long Noncoding RNAs CARMN, LUCAT1, SMILR, and MALAT1 in Thoracic Aortic Aneurysm: Validation of Biomarkers in Clinical Samples.

Authors:  Vaiva Patamsytė; Giedrius Žukovas; Dovydas Gečys; Diana Žaliaduonytė; Povilas Jakuška; Rimantas Benetis; Vaiva Lesauskaitė
Journal:  Dis Markers       Date:  2020-06-17       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.